OptimizeRx (OPRX) Total Debt (2010 - 2026)

OptimizeRx (OPRX) has 6 years of Total Debt data on file, last reported at $23.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt fell 37.06% year-over-year to $23.3 million; the trailing twelve-month figure through Mar 2026 stood at $23.3 million (down 37.06% YoY), and the FY2025 full-year result was $25.7 million, down 21.76% from the prior year.
• Total Debt declined to $23.3 million in Q1 2026, from $25.7 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $37.1 million in Q1 2025 to a low of $23.3 million in Q1 2026.
• A 4-year average of $32.7 million and a median of $34.0 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt grew 3.28% in 2025 and plunged 37.06% in 2026, its largest moves.
• Tracing OPRX's Total Debt over 4 years: stood at $36.2 million in 2023, then declined by 9.43% to $32.8 million in 2024, then slipped by 21.76% to $25.7 million in 2025, then dropped by 9.09% to $23.3 million in 2026.
• Business Quant data shows OPRX's Total Debt at $23.3 million in Q1 2026, $25.7 million in Q4 2025, and $32.1 million in Q3 2025.